Article

The loss of progesterone receptor predicts more aggressive biological features and worse outcomes in estrogen receptor-positive and HER2-negative inflammatory breast cancer

2023-08-10

Abstract excerpt

<title>Abstract</title><p>Objective The loss of progesterone receptor (PR) often predicts worse biological behavior and prognosis in estrogen receptor-positive (ER+) breast cancer. However, the impact of PR status on inflammatory breast cancer (IBC) has not been studied for its’ relative low incidence. Therefore, the purpose of our study was to investigate the influence of PR on IBC. Methods Patients with ER + and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a3f67d3a-e454-5301-9bab-2f326749f819
DOI: 10.21203/rs.3.rs-3221306/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The loss of progesterone receptor predicts more aggressive biological features and worse outcomes in estrogen receptor-positive and HER2-negative inflammatory breast cancerDOI 10.21203/rs.3.rs-3221306/v1Read

ER+/PR- phenotype exhibits more aggressive biological features and worse outcome compared with ER+/PR+ phenotype in HER2-negative inflammatory breast cancer.Semantic proximity Read

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.Semantic proximity Read

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.Semantic proximity Read

Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.Semantic proximity Read

Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapySemantic proximity Read

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBCSemantic proximity Read

Genetic and clinical landscape of ER + /PR- breast cancer in China.Semantic proximity Read

The estrogen receptor negative-progesterone receptor positive breast carcinoma is a biological entity and not a technical artifact.Semantic proximity Read

Breast cancer: An insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugsSemantic proximity Read

Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.Semantic proximity Read

Progesterone-Independent Effects of Human Progesterone Receptors (PRs) in Estrogen Receptor-Positive Breast Cancer: PR Isoform-Specific Gene Regulation and Tumor BiologySemantic proximity Read

Prognostic Impact of ER-Staining Patterns and Heterogeneity of ER positive HER2 negative Breast CancerSemantic proximity Read